Vertaling van "treatment‰ and „trial " (Frans → Nederlands) :

The graphs „Medical treatment‰ and „trial centres‰ show the results of the ACST/ACAS trials (expressed as constant hazards of stroke or death from the trials and age dependent hazards of all other cause mortality from the Flemish male life table at age 70 in the year 2000). 18 Intervention starts with a short period of high (peri-procedural) mortality, but the lower post-procedural hazard of death will overtake the higher hazard of medical treatment.
The graphs „Medical treatment‰ and „trial centres‰ show the results of the ACST/ACAS trials (expressed as constant hazards of stroke or death from the trials and age dependent hazards of all other cause mortality from the Flemish male life table at age 70 in the year 2000).[18] Intervention starts with a short period of high (peri-procedural) mortality, but the lower post-procedural hazard of death will overtake the higher hazard of medical treatment.

Older trials showed poor outcomes, and two randomised trials of carotid stenting were stopped early after these poor outcomes in stented patients.16 These early trials used techniques which have now been superseded, but the safety of endovascular treatment remains as yet insufficiently known.
Older trials showed poor outcomes, and two randomised trials of carotid stenting were stopped early after these poor outcomes in stented patients. 16 These early trials used techniques which have now been superseded, but the safety of endovascular treatment remains as yet insufficiently known.

L, et al. Single-center trials show larger treatment effects than multicenter trials: evidence from a metaepidemiologic study.
L, et al. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study.

The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2002 ; 288 : 2981-2997 (5) PAHOR M, PSATY B, ALERMAN M et al. Health outcomes associated with antagonists compared with other firstlineantihypertensive therapies : a meta-analysis of randomised controlled trials.
The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT).JAMA 2002; 288: 2981-2997 (5) PAHOR M, PSATY B, ALERMAN M et al. Health outcomes associated with antagonists compared with other firstline antihypertensive therapies : a meta-analysis of randomised controlled trials.

Boutitie F, Pinede L, Schulman S et al. Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participant’s data from seven trials. BMJ 2011; 342:d3036.
Campbell IA, Bentley DP, Prescott RJ et al. Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both; randomized trial.

Aliment Pharamcol Ther 2009; 29:55-68. van Marrewijk C, Mujakovic S, Fransen G et al. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): primary-care-based randomised controlled trial.
Aliment Pharamcol Ther 2009; 29:55-68. Numans ME, de Wit NJ, Dirven JAM et al. NHG Standaard Maagklachten, tweede herziening.

32. Sano M , Ernesto C, Thomas RG et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease.
32.Sano M , Ernesto C, Thomas RG et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease.

randomized trials.1 Effective strategies for the secondary prevention of stroke include treatment of hypertension and hyperlipidemia, antithrombotic therapy for patients with atrial fibrillation, and antiplatelet therapy (Evidence level 1). 1 Statins are effective in the prevention of stroke, although evidence remains limited to heart disease patients (Evidence level 1). 2, 3
treatment of hypertension and hyperlipidemia, antithrombotic therapy for patients with atrial fibrillation, and antiplatelet therapy (Evidence level 1).1 Statins are effective in the prevention of stroke, although evidence remains limited to heart disease patients (Evidence level 1).2, 3

DOI : 10.1002/ 14651858.CD008143.pub2. Boussageon R, Bejan-Angoulvant T, Saadatian M et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.
Boussageon R, Bejan-Angoulvant T, Saadatian M et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.

Science M, Johnstone J, Roth DE et al. Zinc for the treatment of the common cold : a systematic review and meta-analysis of randomized controlled trials.
Wilkinson EAJ, Hawke CC. Oral zinc for arterial and venous leg ulcers. Cochrane Database of Systematic Reviews 1998, Issue.